In the last 12 months, insiders at PLIANT THERAPEUTICS, INC. ($PLRX) filed 75 transactions with the SEC: 0 open-market purchases totaling $0 and 21 sales totaling $3,631,131. Net insider sentiment: net selling.
PLIANT THERAPEUTICS, INC. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Coulie Bernard (President and CEO) — 10 transactions totaling $1,592,211
- Cummings Keith Lamont (Chief Financial Officer) — 12 transactions totaling $594,740
- Lefebvre Eric (Chief Medical Officer) — 8 transactions totaling $526,764
- Hull Hans (Chief Business Officer) — 8 transactions totaling $461,558
- Ouimette Mike (General Counsel & Corp. Sec'y) — 9 transactions totaling $439,149
View all SEC Filings for PLIANT THERAPEUTICS, INC. (PLRX).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 22, 2026 | Kuo Minnie | Chief Operating Officer | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 61,449,385 | 9999.99% | 0.49% |
| Jan. 22, 2026 | Cummings Keith Lamont | Chief Financial Officer | A | Stock Option (Right to Buy) | 400000 | $0.00 | 400,000.0000 | 61,449,385 | 9999.99% | 0.65% |
| Jan. 22, 2026 | Cheung Lily | Chief Human Resource Officer | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 61,449,385 | 9999.99% | 0.49% |
| Jan. 22, 2026 | Coulie Bernard | President and CEO | A | Stock Option (Right to Buy) | 1230000 | $0.00 | 1,230,000.0000 | 61,449,385 | 9999.99% | 2.00% |
| Jan. 20, 2026 | Coulie Bernard | President and CEO | S | Common Stock | 89375 | $1.28 | 914,918.0000 | 61,449,385 | 8.90% | 0.15% |
| Jan. 20, 2026 | Cummings Keith Lamont | Chief Financial Officer | S | Common Stock | 24002 | $1.28 | 297,214.0000 | 61,449,385 | 7.47% | 0.04% |
| Jan. 20, 2026 | Kuo Minnie | Chief Operating Officer | S | Common Stock | 6917 | $1.28 | 37,806.0000 | 61,449,385 | 15.47% | 0.01% |
| Jan. 20, 2026 | Cheung Lily | Chief Human Resource Officer | S | Common Stock | 7534 | $1.28 | 44,847.0000 | 61,449,385 | 14.38% | 0.01% |
| June 5, 2025 | Cline Darren S | Director | A | Common Stock (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 61,236,291 | 9999.99% | 0.05% |
| June 5, 2025 | PYOTT DAVID E I | Director | A | Common Stock (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 61,236,291 | 9999.99% | 0.05% |
| June 5, 2025 | Huh Hoyoung | Director | A | Common Stock (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 61,236,291 | 9999.99% | 0.05% |
| June 5, 2025 | CROWELL GAYLE A | Director | A | Common Stock (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 61,236,291 | 9999.99% | 0.05% |
| June 5, 2025 | Knobil Katharine | Director | A | Common Stock (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 61,236,291 | 9999.99% | 0.05% |
| June 5, 2025 | MCCOURT Thomas A | Director | A | Common Stock (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 61,236,291 | 9999.99% | 0.05% |
| June 5, 2025 | Curnutte John T | Director | A | Common Stock (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 61,236,291 | 9999.99% | 0.05% |
| June 5, 2025 | Krognes Steve E. | Director | A | Common Stock (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 61,236,291 | 9999.99% | 0.05% |
| June 5, 2025 | Bruhn Suzanne Louise | Director | A | Common Stock (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 61,236,291 | 9999.99% | 0.05% |
| Jan. 23, 2025 | Cummings Keith Lamont | Chief Financial Officer | A | Common Stock | 56650 | $0.00 | 319,258.0000 | 0 | 21.57% | 0.00% |
| Jan. 23, 2025 | Cummings Keith Lamont | Chief Financial Officer | A | Stock Option (Right to Buy) | 113300 | $0.00 | 113,300.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2025 | Coulie Bernard | President and CEO | A | Common Stock | 162500 | $0.00 | 1,002,334.0000 | 0 | 19.35% | 0.00% |
| Jan. 23, 2025 | Coulie Bernard | President and CEO | A | Stock Option (Right to Buy) | 325000 | $0.00 | 325,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2025 | Cheung Lily | Chief Human Resource Officer | A | Stock Option (Right to Buy) | 51750 | $0.00 | 51,750.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2025 | Cheung Lily | Chief Human Resource Officer | A | Common Stock | 25875 | $0.00 | 50,425.0000 | 0 | 105.40% | 0.00% |
| Jan. 23, 2025 | Ouimette Mike | General Counsel & Corp. Sec'y | A | Common Stock | 35000 | $0.00 | 105,544.0000 | 0 | 49.61% | 0.00% |
| Jan. 23, 2025 | Ouimette Mike | General Counsel & Corp. Sec'y | A | Stock Option (Right to Buy) | 70000 | $0.00 | 70,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2025 | Hull Hans | Chief Business Officer | A | Common Stock | 40150 | $0.00 | 283,499.0000 | 0 | 16.50% | 0.00% |
| Jan. 23, 2025 | Hull Hans | Chief Business Officer | A | Stock Option (Right to Buy) | 80300 | $0.00 | 80,300.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2025 | Lefebvre Eric | Chief Medical Officer | A | Common Stock | 45650 | $0.00 | 240,224.0000 | 0 | 23.46% | 0.00% |
| Jan. 23, 2025 | Lefebvre Eric | Chief Medical Officer | A | Stock Option (Right to Buy) | 91300 | $0.00 | 91,300.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2025 | Lefebvre Eric | Chief Medical Officer | S | Common Stock | 18478 | $11.20 | 194,574.0000 | 0 | 8.67% | 0.00% |
| Jan. 17, 2025 | Cheung Lily | Chief Human Resource Officer | S | Common Stock | 3740 | $11.20 | 24,550.0000 | 0 | 13.22% | 0.00% |
| Jan. 17, 2025 | Ouimette Mike | General Counsel & Corp. Sec'y | S | Common Stock | 13270 | $11.20 | 80,774.0000 | 0 | 14.11% | 0.00% |
| Jan. 22, 2025 | Ouimette Mike | General Counsel & Corp. Sec'y | S | Common Stock | 10230 | $10.99 | 70,544.0000 | 0 | 12.66% | 0.00% |
| Jan. 17, 2025 | Coulie Bernard | President and CEO | S | Common Stock | 52419 | $11.20 | 839,834.0000 | 0 | 5.87% | 0.00% |
| Jan. 17, 2025 | Cummings Keith Lamont | Chief Financial Officer | S | Common Stock | 20148 | $11.20 | 262,608.0000 | 0 | 7.13% | 0.00% |
| Jan. 17, 2025 | Hull Hans | Chief Business Officer | S | Common Stock | 15936 | $11.20 | 243,349.0000 | 0 | 6.15% | 0.00% |
| July 10, 2024 | Lefebvre Eric | Chief Medical Officer | S | Common Stock | 12319 | $11.56 | 213,052.0000 | 0 | 5.47% | 0.00% |
| July 10, 2024 | Cummings Keith Lamont | Chief Financial Officer | S | Common Stock | 10911 | $11.56 | 282,115.0000 | 0 | 3.72% | 0.00% |
| July 10, 2024 | Coulie Bernard | President and CEO | S | Common Stock | 38710 | $11.56 | 892,253.0000 | 0 | 4.16% | 0.00% |
| July 10, 2024 | Ouimette Mike | General Counsel & Corp. Sec'y | S | Common Stock | 7656 | $11.56 | 94,044.0000 | 0 | 7.53% | 0.00% |
| July 10, 2024 | Hull Hans | Chief Business Officer | S | Common Stock | 9900 | $11.56 | 259,285.0000 | 0 | 3.68% | 0.00% |
| July 9, 2024 | Ouimette Mike | General Counsel & Corp. Sec'y | A | Common Stock | 14954 | $0.00 | 101,700.0000 | 0 | 17.24% | 0.00% |
| July 9, 2024 | Lefebvre Eric | Chief Medical Officer | A | Common Stock | 24063 | $0.00 | 225,371.0000 | 0 | 11.95% | 0.00% |
| July 9, 2024 | Hull Hans | Chief Business Officer | A | Common Stock | 19337 | $0.00 | 269,185.0000 | 0 | 7.74% | 0.00% |
| July 9, 2024 | Cummings Keith Lamont | Chief Financial Officer | A | Common Stock | 21313 | $0.00 | 293,026.0000 | 0 | 7.84% | 0.00% |
| July 9, 2024 | Coulie Bernard | President and CEO | A | Common Stock | 75625 | $0.00 | 930,963.0000 | 0 | 8.84% | 0.00% |
| June 13, 2024 | Curnutte John T | Director | A | Common Stock (Right to Buy) | 26764 | $0.00 | 26,764.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Krognes Steve E. | Director | A | Common Stock (Right to Buy) | 53528 | $0.00 | 53,528.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Bruhn Suzanne Louise | Director | A | Common Stock (Right to Buy) | 26764 | $0.00 | 26,764.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | CROWELL GAYLE A | Director | A | Common Stock (Right to Buy) | 26764 | $0.00 | 26,764.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Cline Darren S | Director | A | Common Stock (Right to Buy) | 26764 | $0.00 | 26,764.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Shah Smital | Director | A | Common Stock (Right to Buy) | 26764 | $0.00 | 26,764.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | PYOTT DAVID E I | Director | A | Common Stock (Right to Buy) | 26764 | $0.00 | 26,764.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Huh Hoyoung | Director | A | Common Stock (Right to Buy) | 26764 | $0.00 | 26,764.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | Knobil Katharine | Director | A | Common Stock (Right to Buy) | 26764 | $0.00 | 26,764.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2024 | MCCOURT Thomas A | Director | A | Common Stock (Right to Buy) | 26764 | $0.00 | 26,764.0000 | 0 | 9999.99% | 0.00% |
| May 2, 2024 | Cummings Keith Lamont | Chief Financial Officer | M | Stock Option (Right to Buy) | 21000 | $0.00 | 76,047.0000 | 0 | 21.64% | 0.00% |
| May 2, 2024 | Cummings Keith Lamont | Chief Financial Officer | M | Common Stock | 21000 | $2.08 | 271,713.0000 | 0 | 8.38% | 0.00% |
| Jan. 23, 2024 | Cheung Lily | Chief Human Resource Officer | A | Common Stock | 26000 | $0.00 | 26,795.0000 | 0 | 3270.44% | 0.00% |
| Jan. 23, 2024 | Cheung Lily | Chief Human Resource Officer | A | Stock Option (Right to Buy) | 52000 | $0.00 | 52,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Coulie Bernard | President and CEO | A | Common Stock | 128150 | $0.00 | 853,849.0000 | 0 | 17.66% | 0.00% |
| Jan. 23, 2024 | Coulie Bernard | President and CEO | A | Stock Option (Right to Buy) | 256300 | $0.00 | 256,300.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Cummings Keith Lamont | Chief Financial Officer | A | Common Stock | 55250 | $0.00 | 249,855.0000 | 0 | 28.39% | 0.00% |
| Jan. 23, 2024 | Cummings Keith Lamont | Chief Financial Officer | A | Stock Option (Right to Buy) | 110500 | $0.00 | 110,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Lefebvre Eric | Chief Medical Officer | A | Stock Option (Right to Buy) | 85800 | $0.00 | 85,800.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Hull Hans | Chief Business Officer | A | Common Stock | 31500 | $0.00 | 248,360.0000 | 0 | 14.53% | 0.00% |
| Jan. 23, 2024 | Hull Hans | Chief Business Officer | A | Stock Option (Right to Buy) | 63000 | $0.00 | 63,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Ouimette Mike | General Counsel & Corp. Sec'y | A | Common Stock | 31500 | $0.00 | 86,746.0000 | 0 | 57.02% | 0.00% |
| Jan. 23, 2024 | Ouimette Mike | General Counsel & Corp. Sec'y | A | Stock Option (Right to Buy) | 63000 | $0.00 | 63,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Lefebvre Eric | Chief Medical Officer | A | Common Stock | 42900 | $0.00 | 199,820.0000 | 0 | 27.34% | 0.00% |
| Jan. 17, 2024 | Coulie Bernard | President and CEO | S | Common Stock | 25721 | $17.23 | 725,699.0000 | 0 | 3.42% | 0.00% |
| Jan. 17, 2024 | Lefebvre Eric | Chief Medical Officer | S | Common Stock | 10295 | $17.23 | 156,920.0000 | 0 | 6.16% | 0.00% |
| Jan. 17, 2024 | Ouimette Mike | General Counsel & Corp. Sec'y | S | Common Stock | 5197 | $17.23 | 55,246.0000 | 0 | 8.60% | 0.00% |
| Jan. 17, 2024 | Hull Hans | Chief Business Officer | S | Common Stock | 9786 | $17.23 | 216,860.0000 | 0 | 4.32% | 0.00% |
| Jan. 17, 2024 | Cummings Keith Lamont | Chief Financial Officer | S | Common Stock | 9781 | $17.23 | 194,605.0000 | 0 | 4.79% | 0.00% |